...
首页> 外文期刊>Respiratory medicine >Hydrolytic enzyme of the alveolar macrophage in diffuse pulmonary interstitial disease
【24h】

Hydrolytic enzyme of the alveolar macrophage in diffuse pulmonary interstitial disease

机译:弥漫性肺间质疾病中肺泡巨噬细胞的水解酶

获取原文
获取原文并翻译 | 示例

摘要

Hydrolytic enzymes [acid phosphatase, β-glucuronidase, β-D-N-acetyl glucosaminidase (β-D-NAGA), lysozyme and angiotensin-converting enzyme (ACE)] are the major constituents of alveolar macrophages (AM). These enzymes play a crucial role in the pathogenesis of interstitial lung diseases. Cell-associated activity of several enzymes in alveolar macrophages obtained from control subjects (n = 5) and patients suffering five representative types of interstitial pulmonary diseases [sarcoidosis (n = 10), extrinsic allergic alveolitis (n = 5), idiopathic pulmonary fibrosis (n = 5), neoplastic infiltration of the lung (n = 5) and Pneumocystis carinii pneumonia (n = 5)] were evaluated. Cells were obtained by bronchoalveolar lavage and isolated by Ficoll-Hypaque gradient. Enzymatic activity was assessed by standardized tests. Bronchoalveolar lavage (BAL) lymphocyte counts were significantly elevated in the patients with active sarcoidosis (median: 57%), allergic extrinsic alveolitis (median: 51%) and neoplasic infiltration (median: 31%) as compared with the other groups, whereas BAL neutrophil and eosinophil counts were significantly elevated in the patients with idiopathic pulmonary fibrosis (neutrophil median: 29%; eosinophil median: 3%). The highest alveolar macrophage enzymatic activities were obtained in the active sarcoidosis group (median ACE: 23.38 μKat 10~(-6) AM; median lysozyme: 8.64 nKat 10~(-6) AM; median β-glucuronidase: 324.22 U 10~(-6) AM; median acid phosphatase: 0.78 nKat 10~(-6) AM; median β-D-NAGA: 1.85 nKat 10~(-6) AM) which was significantly greater than in the control group (median ACE: 6.69 μKat 10~(-6) AM; median lysozyme: 1.95 nKat 10~(-6) AM; median β-glucuronidase: 39.88 U 10~(-6) AM; median acid phosphatase: 0.38 nKat 10~(-6) AM; median β-D-NAGA: 0.44 nKat 10~(-6) AM). However, intracellular lysosomal enzymatic activities of alveolar macrophages from patients with allergic extrinsic alveolitis, a disease in which the degree of alveolar macrophage activation is maximal, were similar to those of the control group. These findings demonstrated a different pattern of expression of alveolar macrophage's hydrolytic enzymes in lymphocytic diffuse pulmonary interstitial disease. In sarcoidotic patients, hydrolytic enzymes were increased whereas in allergic extrinsic alveolitis, hydrolytic enzyme activities were similar to control groups. Indirect data suggest that the release of lysosomal enzymes by alveolar macrophages during allergic extrinsic alveolitis may be a factor involved in the pulmonary lesions appearing in this disease.
机译:水解酶[酸性磷酸酶,β-葡萄糖醛酸苷酶,β-D-N-乙酰氨基葡萄糖苷酶(β-D-NAGA),溶菌酶和血管紧张素转化酶(ACE)]是肺泡巨噬细胞(AM)的主要成分。这些酶在间质性肺疾病的发病机理中起关键作用。从对照受试者(n = 5)和患有五种代表性类型的间质性肺病[结节病(n = 10),外源性过敏性肺泡炎(n = 5),特发性肺纤维化(5种)的患者的肺泡巨噬细胞中几种酶的细胞相关活性n = 5),评估了肺部肿瘤浸润(n = 5)和卡氏肺孢子虫肺炎(n = 5)]。通过支气管肺泡灌洗获得细胞,并通过Ficoll-Hypaque梯度分离。通过标准化测试评估酶活性。与其他组相比,活动性结节病(中位数:57%),过敏性外源性肺泡炎(中位数:51%)和赘生性浸润(中位数:31%)患者的支气管肺泡灌洗(BAL)淋巴细胞计数显着升高。特发性肺纤维化患者的中性粒细胞和嗜酸性粒细胞计数显着升高(中性粒细胞中位数:29%;嗜酸性粒细胞中位数:3%)。在活跃结节病组中,肺泡巨噬细胞的酶活性最高(ACE中位数:23〜38μKat10〜(-6)AM;中位数溶菌酶:8.64 nKat 10〜(-6)AM;β-葡糖醛酸糖苷酶的中位数:324.22 U 10〜( -6)AM;酸性磷酸酶中位数:0.78 nKat 10〜(-6)AM;β-D-NAGA中位数:1.85 nKat 10〜(-6)AM),显着高于对照组(ACE中位数:6.69) μKat10〜(-6)AM;中位数溶菌酶:1.95 nKat 10〜(-6)AM;β-葡萄糖醛酸苷酸酶中位数:39.88 U 10〜(-6)AM;中性酸性磷酸酶:0.38 nKat 10〜(-6)AM ;中位数β-D-NAGA:在10〜(-6)AM时为0.44 nKat)。但是,来自过敏性外源性肺泡炎的患者的肺泡巨噬细胞的胞内溶酶体酶活性与肺泡巨噬细胞活化程度最大的疾病相似。这些发现证明了在肺弥漫性肺间质疾病中肺泡巨噬细胞水解酶表达的不同模式。在结节病患者中,水解酶增加,而在过敏性外源性肺泡炎中,水解酶活性与对照组相似。间接数据表明,在过敏性外源性肺泡炎期间,肺泡巨噬细胞释放溶酶体酶可能是该疾病出现肺部病变的一个因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号